nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—Signaling events regulated by Ret tyrosine kinase—PDLIM7—pharynx cancer	0.0405	0.0957	CbGpPWpGaD
Sulindac—MAPK3—mouth—pharynx cancer	0.0384	0.0665	CbGeAlD
Sulindac—AKR1B1—parotid gland—pharynx cancer	0.0369	0.0639	CbGeAlD
Sulindac—AKR1B1—saliva-secreting gland—pharynx cancer	0.0353	0.0612	CbGeAlD
Sulindac—MAPK3—neck—pharynx cancer	0.0328	0.0569	CbGeAlD
Sulindac—AKR1B1—epithelium—pharynx cancer	0.0308	0.0534	CbGeAlD
Sulindac—AKR1B1—trachea—pharynx cancer	0.0272	0.0472	CbGeAlD
Sulindac—MAPK3—parotid gland—pharynx cancer	0.0267	0.0463	CbGeAlD
Sulindac—MAPK3—saliva-secreting gland—pharynx cancer	0.0256	0.0444	CbGeAlD
Sulindac—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0239	0.0564	CbGpPWpGaD
Sulindac—AKR1B1—lymphoid tissue—pharynx cancer	0.0237	0.0411	CbGeAlD
Sulindac—MAPK3—epithelium—pharynx cancer	0.0223	0.0387	CbGeAlD
Sulindac—AKR1B1—spinal cord—pharynx cancer	0.0215	0.0373	CbGeAlD
Sulindac—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.021	0.0495	CbGpPWpGaD
Sulindac—MAPK3—trachea—pharynx cancer	0.0197	0.0342	CbGeAlD
Sulindac—AKR1B1—head—pharynx cancer	0.0191	0.0331	CbGeAlD
Sulindac—PPARD—lymphoid tissue—pharynx cancer	0.0186	0.0323	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—pharynx cancer	0.0172	0.0298	CbGeAlD
Sulindac—MAPK3—TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer—EGFR—pharynx cancer	0.0172	0.0406	CbGpPWpGaD
Sulindac—MAPK3—spinal cord—pharynx cancer	0.0156	0.027	CbGeAlD
Sulindac—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0152	0.036	CbGpPWpGaD
Sulindac—PPARD—NRF2 pathway—ADH7—pharynx cancer	0.0151	0.0357	CbGpPWpGaD
Sulindac—PPARD—head—pharynx cancer	0.015	0.0261	CbGeAlD
Sulindac—MAPK3—head—pharynx cancer	0.0139	0.024	CbGeAlD
Sulindac—AKR1B1—lymph node—pharynx cancer	0.0134	0.0232	CbGeAlD
Sulindac—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0134	0.0316	CbGpPWpGaD
Sulindac—CYP1A1—mouth—pharynx cancer	0.0119	0.0206	CbGeAlD
Sulindac—PPARD—lymph node—pharynx cancer	0.0105	0.0182	CbGeAlD
Sulindac—PTGS2—mouth—pharynx cancer	0.00997	0.0173	CbGeAlD
Sulindac—MAPK3—lymph node—pharynx cancer	0.0097	0.0168	CbGeAlD
Sulindac—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00955	0.0226	CbGpPWpGaD
Sulindac—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00838	0.0198	CbGpPWpGaD
Sulindac—CYP1A1—parotid gland—pharynx cancer	0.00826	0.0143	CbGeAlD
Sulindac—PPARD—Presenilin action in Notch and Wnt signaling—CCND1—pharynx cancer	0.00726	0.0172	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—CNDP2—pharynx cancer	0.00693	0.0164	CbGpPWpGaD
Sulindac—CYP1A1—epithelium—pharynx cancer	0.0069	0.012	CbGeAlD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00673	0.0159	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—CD79A—pharynx cancer	0.00661	0.0156	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—ADH7—pharynx cancer	0.00626	0.0148	CbGpPWpGaD
Sulindac—CYP1A1—trachea—pharynx cancer	0.00611	0.0106	CbGeAlD
Sulindac—PTGS1—epithelium—pharynx cancer	0.00607	0.0105	CbGeAlD
Sulindac—MAPK3—IL-7 Signaling Pathway—CCND1—pharynx cancer	0.00604	0.0143	CbGpPWpGaD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0059	0.0139	CbGpPWpGaD
Sulindac—PTGS2—epithelium—pharynx cancer	0.0058	0.0101	CbGeAlD
Sulindac—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.00561	0.0132	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—ADH1B—pharynx cancer	0.00549	0.013	CbGpPWpGaD
Sulindac—MAPK3—Signal transduction by L1—EGFR—pharynx cancer	0.00545	0.0129	CbGpPWpGaD
Sulindac—MAPK3—GRB2 events in EGFR signaling—EGFR—pharynx cancer	0.00545	0.0129	CbGpPWpGaD
Sulindac—PTGS1—trachea—pharynx cancer	0.00536	0.0093	CbGeAlD
Sulindac—MAPK3—SHC1 events in EGFR signaling—EGFR—pharynx cancer	0.00525	0.0124	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—B4GALT5—pharynx cancer	0.00525	0.0124	CbGpPWpGaD
Sulindac—PTGS2—trachea—pharynx cancer	0.00513	0.00889	CbGeAlD
Sulindac—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.00507	0.012	CbGpPWpGaD
Sulindac—ALB—lymph node—pharynx cancer	0.00463	0.00802	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—pharynx cancer	0.00447	0.00774	CbGeAlD
Sulindac—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.00445	0.0105	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—CDH1—pharynx cancer	0.00438	0.0103	CbGpPWpGaD
Sulindac—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00431	0.0102	CbGpPWpGaD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00429	0.0101	CbGpPWpGaD
Sulindac—CYP1A1—head—pharynx cancer	0.00428	0.00743	CbGeAlD
Sulindac—PTGS1—spinal cord—pharynx cancer	0.00424	0.00735	CbGeAlD
Sulindac—MAPK3—GRB2 events in ERBB2 signaling—EGFR—pharynx cancer	0.0041	0.00967	CbGpPWpGaD
Sulindac—PTGS2—spinal cord—pharynx cancer	0.00405	0.00702	CbGeAlD
Sulindac—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.00395	0.00934	CbGpPWpGaD
Sulindac—MAPK3—SHC1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00389	0.00919	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—pharynx cancer	0.00384	0.00907	CbGpPWpGaD
Sulindac—PTGS1—head—pharynx cancer	0.00376	0.00653	CbGeAlD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00376	0.00889	CbGpPWpGaD
Sulindac—MAPK3—Presenilin action in Notch and Wnt signaling—CCND1—pharynx cancer	0.00371	0.00876	CbGpPWpGaD
Sulindac—PTGS2—head—pharynx cancer	0.0036	0.00624	CbGeAlD
Sulindac—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.00357	0.00844	CbGpPWpGaD
Sulindac—MAPK3—CDC42 signaling events—CDH1—pharynx cancer	0.00356	0.0084	CbGpPWpGaD
Sulindac—MAPK3—Oncogene Induced Senescence—TP53—pharynx cancer	0.00344	0.00812	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDH1—pharynx cancer	0.0032	0.00755	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.00313	0.0074	CbGpPWpGaD
Sulindac—MAPK3—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00304	0.00718	CbGpPWpGaD
Sulindac—CYP1A1—lymph node—pharynx cancer	0.003	0.0052	CbGeAlD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—CCND1—pharynx cancer	0.00296	0.00699	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—CCND1—pharynx cancer	0.00271	0.00641	CbGpPWpGaD
Sulindac—PTGS1—lymph node—pharynx cancer	0.00264	0.00457	CbGeAlD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—pharynx cancer	0.00253	0.00598	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00252	0.00595	CbGpPWpGaD
Sulindac—PTGS2—lymph node—pharynx cancer	0.00252	0.00437	CbGeAlD
Sulindac—MAPK3—Leptin signaling pathway—CCND1—pharynx cancer	0.00251	0.00592	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CNDP2—pharynx cancer	0.00251	0.00592	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00234	0.00552	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00228	0.00538	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ADH7—pharynx cancer	0.00227	0.00536	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—EGFR—pharynx cancer	0.00218	0.00515	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00215	0.00509	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—EGFR—pharynx cancer	0.00213	0.00503	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.002	0.00472	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ADH1B—pharynx cancer	0.00199	0.0047	CbGpPWpGaD
Sulindac—PPARD—Metabolism—B4GALT5—pharynx cancer	0.0019	0.00449	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00185	0.00438	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00183	0.00433	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00181	0.00427	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00181	0.00427	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—CCND1—pharynx cancer	0.00175	0.00412	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00173	0.00409	CbGpPWpGaD
Sulindac—MAPK3—L1CAM interactions—EGFR—pharynx cancer	0.00162	0.00381	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—pharynx cancer	0.00159	0.00374	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00154	0.00363	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00154	0.00363	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00154	0.00363	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00154	0.00363	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—EGFR—pharynx cancer	0.0015	0.00355	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.00142	0.00334	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—EGFR—pharynx cancer	0.00137	0.00323	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.00136	0.00322	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00119	0.0028	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00119	0.0028	CbGpPWpGaD
Sulindac—MAPK3—Disease—B4GALT5—pharynx cancer	0.00116	0.00274	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—pharynx cancer	0.00115	0.00272	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—pharynx cancer	0.00114	0.0027	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00114	0.00268	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00114	0.00268	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—EGFR—pharynx cancer	0.00112	0.00264	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—EGFR—pharynx cancer	0.00107	0.00252	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—EGFR—pharynx cancer	0.00106	0.00251	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—EGFR—pharynx cancer	0.00106	0.0025	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—EGFR—pharynx cancer	0.00105	0.00249	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.00104	0.00245	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00103	0.00244	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—EGFR—pharynx cancer	0.00099	0.00234	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00099	0.00234	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00099	0.00234	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—EGFR—pharynx cancer	0.000981	0.00232	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000979	0.00231	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000979	0.00231	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000973	0.0023	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—EGFR—pharynx cancer	0.000968	0.00229	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CNDP2—pharynx cancer	0.000959	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000932	0.0022	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—pharynx cancer	0.000881	0.00208	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000877	0.00207	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ADH7—pharynx cancer	0.000868	0.00205	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—pharynx cancer	0.000867	0.00205	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—pharynx cancer	0.000855	0.00202	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000847	0.002	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.000814	0.00192	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—pharynx cancer	0.000799	0.00189	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000782	0.00185	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CNDP2—pharynx cancer	0.000762	0.0018	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ADH1B—pharynx cancer	0.000761	0.0018	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.000727	0.00172	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000706	0.00167	CbGpPWpGaD
Sulindac—PTGS2—Disease—B4GALT5—pharynx cancer	0.000689	0.00163	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ADH7—pharynx cancer	0.000689	0.00163	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—pharynx cancer	0.000688	0.00162	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.000684	0.00162	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.000676	0.0016	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—pharynx cancer	0.000675	0.00159	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCND1—pharynx cancer	0.000643	0.00152	CbGpPWpGaD
Sulindac—ALB—Metabolism—CNDP2—pharynx cancer	0.000616	0.00146	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADH7—pharynx cancer	0.000611	0.00144	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—pharynx cancer	0.00061	0.00144	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000604	0.00143	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—pharynx cancer	0.000604	0.00143	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.000577	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.000575	0.00136	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADH7—pharynx cancer	0.000557	0.00132	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000554	0.00131	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.000536	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CCND1—pharynx cancer	0.000514	0.00121	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.000512	0.00121	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—pharynx cancer	0.000505	0.00119	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADH1B—pharynx cancer	0.000489	0.00115	CbGpPWpGaD
Sulindac—ALB—Metabolism—B4GALT5—pharynx cancer	0.000467	0.0011	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000465	0.0011	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—pharynx cancer	0.000436	0.00103	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000431	0.00102	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—pharynx cancer	0.000424	0.001	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00039	0.000921	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—pharynx cancer	0.000385	0.000909	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDH1—pharynx cancer	0.000383	0.000905	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—pharynx cancer	0.000359	0.000847	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000342	0.000807	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—pharynx cancer	0.000339	0.0008	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000327	0.000771	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—pharynx cancer	0.000245	0.000579	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—pharynx cancer	0.000224	0.000529	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—pharynx cancer	0.000207	0.000489	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCND1—pharynx cancer	0.000185	0.000436	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—pharynx cancer	0.000173	0.000408	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—pharynx cancer	0.000145	0.000342	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—pharynx cancer	0.000123	0.000291	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—pharynx cancer	0.000122	0.000287	CbGpPWpGaD
